A Child With Friedreich's Ataxia and Epilepsy

Abstract

Epilepsy in Friedreich's ataxia is rare. We describe a 9-year-old boy with Friedreich's ataxia who had onset of symptoms in the second year of life and developed a generalized epilepsy at age 5 years. On cerebral magnetic resonance imaging, he has a subependymal gray-matter heterotopia. We suggest that his gray-matter heterotopia might be related to his diagnosis of Friedreich's ataxia and that his early onset of symptoms might be related to the length of his guanine - adenine - Adenine (GAA) triplet repeat expansion. ( J Child Neurol 2005;20:248—250).

Get full access to this article

View all access options for this article.

References

National Institutes of Health Clinical Research Studies : Phase I clinical trial to establish the maximum tolerated dose of idebenone in children, adolescents and adults with Friedreich's ataxia, protocol 0 1 - N - 0 1 6 7, 2 0 0 3 . A c c e s s e d a t http://clinicalstudies.info.nih.gov/cgi/wais/bold032001.pl?B_01-N-0167.html@Friedreich@ataxia .

Durr A. , Cossee M. , Agid Y. , et al: Clinical and genetic abnormalities in patients with Friedreich's ataxia. N Engl J Med 1996;335:1169—1175.

Spalice A. , Taddeucci G. , Perla FM , et al: Periventricular nodular heterotopia: Report of a pediatric series. J Child Neurol 2002;17:300—304.

Giza CC , Kuratani JD , Cokely H. , Sankar R. : Periventricular nodular heterotopia and childhood absence epilepsy . Pediatr Neurol 1999; 20:315—318.

Jiralerspong S. , Liu Y. , Montermini L. , et al: Frataxin shows developmentally regulated tissue-specific expression in the mouse embryo. Neurobiol Dis 1997;4:103—113.

Keng WT , Pilz DT , Minns B. , FitzPatrick DR : A3243G mitochondrial mutation associated with polymicrogyria. Dev Med Child Neurol 2003;45:704—708.

Zand DJ , Simon EM , Pulitzer SB , et al: In vivo pyruvate detected by MR spectroscopy in neonatal pyruvate dehydrogenase deficiency. AJNR Am J Neuroradiol 2003;24:1471—1474.

Oppenheimer DR : Brain lesions in Friedreich's ataxia. Can J Neurol Sci 1979;6:173—176.

Harding AE : Friedreich's ataxia: A clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features . Brain 1981;104:589—620.

10.

Filla A. , De Michele G , Cavalcanti F. , et al: The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia. Am J Hum Genet 1996;59:554—560.

11.

De Michele G , Filla A. , Criscuolo C. , et al: Determinants of onset age in Friedreich's ataxia. J Neurol 1998;245:166—168.

12.

Artuch R. , Aracil A. , Mas A. , et al: Friedreich's ataxia: Idebenone treatment in early stage patients . Neuropediatrics 2002;33:190—193.

13.

Buyse G. , Mertens L. , Di Salvo G , et al: Idebenone treatment in Friedreich's ataxia: Neurological, cardiac, and biochemical monitoring. Neurology 2003 ;60:1679—1681.

14.

Mariotti C. , Solari A. , Torta D. , et al: Idebenone treatment in Friedreich patients: One-year-long randomized placebo-controlled trial. Neurology 2003;60:1676—1679

15.

Rustin P. , von Kleist-Retzow JC , Chantrel-Groussard K. , et al: Effect of idebenone on cardiomyopathy in Friedreich's ataxia: A preliminary study. Lancet 1999;354:477—479.

16.

Centers for Disease Control and Prevention : Prevalence of self-reported epilepsy—United States, 1986-1990. JAMA 1994;272:1893.